Indore, IN: Bizwit Research & Consulting LLP’s Recent Analysis on Global Breast Biopsy Market is poised to raise up to USD 1.38 billion by 2027. A breast biopsy is a procedure which is used to diagnose breast cancer. This is nevertheless limited to cancer but also many other breast ailments like a lump in the breast and others. A sample of the breast tissue is removed in this procedure and tested in the laboratory to determine the presence of cancerous cells. There are different type of biopsy procedures based on the product such as, vacuum assisted biopsy (VAB), core needle biopsy (CNB), and the fine needle aspiration biopsy (FNAB), advised by the doctor depending on the size , location and other characteristic of the breast abnormally.
Fine needle aspiration biopsy, usually without scarring, is one of the minimally invasive procedures. In this procedure a needle is inserted into the breast to extract the tissue sample via the breast dermal tissue. Rising incidences of breast cancer, and the increasing awareness among people. Moreover, various reimbursement policies for breast biopsy treatment are the few factors responsible for high CAGR of the market during the forecast period. Introduction of technologically advanced and noninvasive breast biopsy devices in the untapped market is expected to provide lucrative growth opportunities.
The global Breast Biopsy market industry is highly competitive owing to the presence of several key manufacturers such as Devicor Medical Products Inc., Hologic Inc., C.R. Bard, Inc, Becton, Dickinson and Company, Argon Medical Devices, Encapsule Medical Devices LLC, Galini SRL, Ethicon Endo Surgery (Johnson and Johnson), Intact Medical Corporation and Cook Medical Incorporated
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Breast Biopsy Market industry is anticipated to grow with a healthy growth rate of more than 20% over the forecast period 2020-2027.
- Breast biopsy is a test performed to eliminate fluid or tissue from the irregular area of the patient’s body, while the removed sample is further examined to check the presence of breast cancer.
- The Breast Biopsy market can be chiefly attributed to the increase in incidence of breast cancer.
- In the forecast period, the Asia-Pacific market is projected to expand with the highest CAGR. This growth can be attributed to increased middle-class purchasing power and increased awareness of the screening of breast cancer.
Bizwit Research & Consulting LLP has considered following segments for the study:
- Needle Breast Biopsy
- Open Surgical Breast Biopsy
- Biopsy Needles
- Guidance Systems
- Biopsy Tables
- Localization Wires
- Mammography-guided Stereotactic
- Magnetic Resonance-guided
- Others (PET, thermography)
- North America
- Asia Pacific
- Latin America
- Rest of the World
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: [email protected]
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Global Business Development
Phone: +91 999 3115879
Email: [email protected]